Posts by: Patricia Inacio PhD

Patricia Inacio PhD

Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.

April 23, 2021April 23, 2021

SAN903, for IPF, Significantly Lessens Fibrosis in Animal Study

News

SAN903, a candidate therapy for idiopathic pulmonary fibrosis (IPF), led to a significant reduction in markers of inflammation and fibrosis (scarring) in a mouse model of induced pulmonary fibrosis (PF), its developer, ... Read more

April 23, 2021April 23, 2021

Quick Approval Given COVID Vaccines Raise Concerns, Rare Disease Patients Say

News, syndicated

More than half of the people with rare diseases and their caregivers, asked in a survey, were undecided or less than willing to be vaccinated for COVID-19 if a vaccine ... Read more

April 16, 2021April 15, 2021

EveryLife Scholarship Fund Open Until May 7 for Adults With Rare Diseases in US

News, syndicated

The EveryLife Foundation for Rare Diseases is accepting applications for a scholarship program that aims to help adults with a rare disease pursue personal goals through training and education. For a ... Read more

January 25, 2021January 25, 2021

At-home Spirometry May Help in Lung Function Monitoring

News

At-home evaluation of lung function using a spirometry device is a “feasible and valid measure” for people with idiopathic pulmonary fibrosis (IPF) who have preserved lung function, clinical trial data ... Read more

January 4, 2021January 4, 2021

Procalcitonin Blood Levels May Help Detect Lung Cancer in IPF Patients, Study Suggests

News

Procalcitonin, a precursor of the calcitonin hormone, may be used as a potential biomarker of lung cancer developing in people with idiopathic pulmonary fibrosis (IPF), a recent study suggests. Compared ... Read more

September 4, 2020September 4, 2020

NIH Grants $10M to Study Immune Cells’ Role in Lung, Heart Transplant Rejection

News

Research investigating the role of immune cells in triggering lung and heart rejection following transplant will be supported by $10 million in grants from the National Institutes of Health (NIH). ... Read more

August 19, 2020August 20, 2020

Gene Therapy Halts Age-related Lung Fibrosis, Mouse Study Shows

News

A gene therapy that lengthens the life of lung cells can halt scarring and help sustain lung regeneration in a mouse model of age-related pulmonary fibrosis, a new study shows. ... Read more

August 12, 2020August 12, 2020

Real-world Data Support Envisia Classifier in More Easily Diagnosing IPF

News

Veracyte’s Envisia Genomic Classifier can aid in the diagnosis of idiopathic pulmonary fibrosis (IPF) and distinguish it from other interstitial lung diseases (ILDs) without the need for invasive, expensive, and risky surgical ... Read more

August 10, 2020August 11, 2020

Potential Cancer Treatment, Barasertib, Might Lessen Lung Fibrosis in IPF

News

Note: This story was updated Aug. 11, 2020, to correct the name of the factor involved in fibrosis to TGF-alpha rather than TNF-alpha. Barasertib, AstraZeneca’s investigational inhibitor of the AURKB ... Read more